SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001209
Filing Date
2019-02-27
Accepted
2019-02-27 17:22:06
Documents
110
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adap-20181231x10k.htm 10-K 3738135
2 EX-23.1 adap-20181231ex23106909f.htm EX-23.1 4464
3 EX-31.1 adap-20181231ex31160c683.htm EX-31.1 17264
4 EX-31.2 adap-20181231ex3127ff02a.htm EX-31.2 17266
5 EX-32.1 adap-20181231ex321e03b5a.htm EX-32.1 6313
6 EX-32.2 adap-20181231ex32290752d.htm EX-32.2 6310
7 GRAPHIC adap20181231x10k001.jpg GRAPHIC 44067
8 GRAPHIC adap20181231x10k002.jpg GRAPHIC 61473
  Complete submission text file 0001558370-19-001209.txt   13452951

Data Files

Seq Description Document Type Size
9 EX-101.INS adap-20181231.xml EX-101.INS 3199719
10 EX-101.SCH adap-20181231.xsd EX-101.SCH 84873
11 EX-101.CAL adap-20181231_cal.xml EX-101.CAL 68013
12 EX-101.DEF adap-20181231_def.xml EX-101.DEF 287627
13 EX-101.LAB adap-20181231_lab.xml EX-101.LAB 688607
14 EX-101.PRE adap-20181231_pre.xml EX-101.PRE 537638
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37368 | Film No.: 19638963
SIC: 2836 Biological Products, (No Diagnostic Substances)